Two cycles of neoadjuvant chemotherapy improves survival in patients with high‐risk upper tract urothelial carcinoma

OBJECTIVES: To assess the impact of two cycles of neoadjuvant chemotherapy (NAC) in patients who underwent nephroureterectomy for high‐risk cN0M0 upper tract urothelial carcinoma (UTUC), and to evaluate the efficacy of NAC in patients with localised disease (≤cT2). PATIENTS AND METHODS: We retrospec...

Descripción completa

Detalles Bibliográficos
Autores principales: Zennami, Kenji, Sumitomo, Makoto, Takahara, Kiyoshi, Nukaya, Takuhisa, Takenaka, Masashi, Fukaya, Kosuke, Ichino, Manabu, Fukami, Naohiko, Sasaki, Hitomi, Kusaka, Mamoru, Shiroki, Ryoichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984033/
https://www.ncbi.nlm.nih.gov/pubmed/32896105
http://dx.doi.org/10.1111/bju.15230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984033/
https://www.ncbi.nlm.nih.gov/pubmed/32896105
http://dx.doi.org/10.1111/bju.15230

Ejemplares similares